Report copyright - Modeling Imatinib-Treated Chronic Myeloid Leukemiarvbalan/TEACHING/AMSC663Fall2015/β¦Β Β· BCR-ABL1 Ratio for duration of treatment (400 days) π β πΏπ ππ‘π = ππ
Please pass captcha verification before submit form